Development of RxSelex: A microbiome-based predictive diagnostic of IBD biologics treatment outcome

Researchers at AlphaBiomics Ltd are looking for patients with IBD who are 18 or older and live in the West Midlands to join a Patient Advisory Group meeting regularly to give their thoughts and input on a publicly-funded research project. This research involvement opportunity will help provide your unique perspective to the research programme.

If you are interested and would like more information about this opportunity, please contact Marcus Rauch at PPI@alphabiomics.com.


This research involvement opportunity is NOT organised by Crohn's & Colitis UK and, therefore, we cannot take responsibility for your involvement.